How to adjust insulin when starting GLP-1, and why hypoglycemia is the main risk.
About this article
Reviewed byDr. Richard Allen, M.D.
RoleEndocrinology Reviewer
First publishedMay 20, 2026
Last reviewedMay 20, 2026
Page typeIn-depth editorial guide
Sources15+ cited sources
Why hypoglycemia happens
GLP-1 RAs alone do not cause hypoglycemia (glucose-dependent insulin secretion). But when added to insulin or sulfonylureas, the combined hypoglycemic effect can be substantial.
Insulin reduction when starting GLP-1
- Basal insulin: reduce 20% at GLP-1 initiation.
- Mealtime insulin: reduce 30–50% (GLP-1 also flattens post-prandial glucose).
- Frequent finger-sticks or CGM critical first 4 weeks.
Sulfonylurea coordination
Reduce sulfonylurea 50% at GLP-1 initiation; consider discontinuation as GLP-1 dose escalates. Many T2D patients on sulfonylureas can discontinue them within 3–6 months on GLP-1.
Symptoms to watch
- Sweating, palpitations, tremor, anxiety, confusion — classic hypoglycemia.
- Frequent <70 mg/dL — call your endocrinologist for med adjustment.
- Severe (<54 mg/dL) or with loss of awareness — urgent care.